全文获取类型
收费全文 | 9907篇 |
免费 | 475篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 237篇 |
妇产科学 | 95篇 |
基础医学 | 1265篇 |
口腔科学 | 217篇 |
临床医学 | 570篇 |
内科学 | 2483篇 |
皮肤病学 | 305篇 |
神经病学 | 959篇 |
特种医学 | 553篇 |
外科学 | 1421篇 |
综合类 | 33篇 |
一般理论 | 1篇 |
预防医学 | 531篇 |
眼科学 | 145篇 |
药学 | 531篇 |
中国医学 | 19篇 |
肿瘤学 | 980篇 |
出版年
2023年 | 43篇 |
2022年 | 34篇 |
2021年 | 148篇 |
2020年 | 92篇 |
2019年 | 134篇 |
2018年 | 182篇 |
2017年 | 171篇 |
2016年 | 195篇 |
2015年 | 213篇 |
2014年 | 270篇 |
2013年 | 341篇 |
2012年 | 591篇 |
2011年 | 642篇 |
2010年 | 379篇 |
2009年 | 358篇 |
2008年 | 552篇 |
2007年 | 652篇 |
2006年 | 651篇 |
2005年 | 631篇 |
2004年 | 654篇 |
2003年 | 639篇 |
2002年 | 623篇 |
2001年 | 184篇 |
2000年 | 126篇 |
1999年 | 146篇 |
1998年 | 138篇 |
1997年 | 118篇 |
1996年 | 112篇 |
1995年 | 126篇 |
1994年 | 94篇 |
1993年 | 83篇 |
1992年 | 121篇 |
1991年 | 105篇 |
1990年 | 95篇 |
1989年 | 104篇 |
1988年 | 87篇 |
1987年 | 69篇 |
1986年 | 58篇 |
1985年 | 64篇 |
1984年 | 49篇 |
1983年 | 40篇 |
1982年 | 27篇 |
1981年 | 35篇 |
1980年 | 32篇 |
1979年 | 35篇 |
1975年 | 18篇 |
1973年 | 20篇 |
1970年 | 23篇 |
1969年 | 18篇 |
1968年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Takahiro Namiki Chika Takano Ryoji Aoki Quang Duy Trinh Ichiro Morioka Satoshi Hayakawa 《Congenital anomalies》2022,62(1):38-41
Congenital rubella syndrome (CRS) results from maternal rubella virus infection in early pregnancy. Abnormal neuroimaging findings have been analyzed in a small number of CRS patients in the past; however, their clinical significance has been poorly addressed. Therefore, we have investigated the neuroimaging findings of 31 patients with CRS from previous studies. The most common finding was parenchymal calcification, which was observed in 18 of 31 patients (58.1%). A multivariable logistic regression model showed that it was associated with psychomotor or mental retardation (p = 0.018), suggesting that parenchymal calcification in CRS could be a prognostic factor. 相似文献
2.
3.
High prevalence of toothache among Great East Japan Earthquake survivors living in temporary housing
4.
Atsushi Hata Takahiro Nakajima Keisuke Matsusaka Masaki Fukuyo Junichi Morimoto Takayoshi Yamamoto Yuichi Sakairi Bahityar Rahmutulla Satoshi Ota Hironobu Wada Hidemi Suzuki Hisahiro Matsubara Ichiro Yoshino Atsushi Kaneda 《International journal of cancer. Journal international du cancer》2020,146(2):388-399
5.
6.
7.
Guide for medical professionals (i.e. dermatologists) for the management of Rhododenol‐induced leukoderma 下载免费PDF全文
Chikako Nishigori Yumi Aoyama Akiko Ito Kayoko Suzuki Tamio Suzuki Atsushi Tanemura Masaaki Ito Ichiro Katayama Naoki Oiso Yuji Kagohashi Shinichi Sugiura Kazuyoshi Fukai Yoko Funasaka Toshiharu Yamashita Kayoko Matsunaga 《The Journal of dermatology》2015,42(2):113-128
Because some users develop depigmentation after the use of melanogenesis‐inhibiting products containing the quasi‐drug ingredient Rhododenol, Japanese Dermatological Association (JDA) established a Special Committee on the Safety of Cosmetics Containing Rhododenol on July 17, 2013 and management guide for dermatologists has been updated on the website in order to delineate the diagnostic criteria for Rhododenol‐induced leukoderma and provides a broad guide for standard treatment based on current knowledge. This guide is produced on the basis of the guide (version 7) updated on June 20, 2014 in the website. Rhododenol‐induced leukoderma refers to depigmentation of varying severity that develops after the use of cosmetics containing Rhododenol, mainly at the site of use. In most cases, repigmentation of part or all the affected area is evident after discontinuation. Histopathologically cellular infiltration around the hair follicles and melanophages are present in most cases. The number of melanocytes in the lesion is declined but not totally absent in most cases. Rhododenol itself is a good substrate for tyrosinase, resulting in the formation of Rhododenol metabolites (e.g., Rhododenol quinone). Melanocytes are damaged by Rhododenol metabolites during the subsequent metabolic process. The continued use of cosmetics containing Rhododenol thus induces tyrosinase activity‐dependent cytotoxicity in melanocytes in the epidermis at application sites, resulting in decreasing the amount of melanin produced by melanocytes; the addition of some other factor to this process is believed to subsequently cause the decrease or disappearance of melanocytes themselves from the epidermis. 相似文献
8.
9.
10.